Real-word efficacy of osimertinib in patients with metastatic EGFRm NSCLC: An interim analysis from a multi-center study in China

Authors
Category Primary study
JournalAnnals of Oncology
Year 2019
This article has no abstract
Epistemonikos ID: 85e43e572ab961c18d58792e99737f6562354acc
First added on: Feb 11, 2025